| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.07B | +4.1% |
| Cost of Revenue | $2.47B | +0.4% |
| Gross Profit | $3.59B | +6.9% |
| R&D Expense | $397.8M | -0.9% |
| SG&A Expense | $2.06B | +5.4% |
| Operating Income | $1.13B | +14.8% |
| Interest Expense | $123.5M | +25.6% |
| Pre-tax Income | $990.8M | +13.4% |
| Income Tax | $125.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.89B | +166.3% |
| Accounts Receivable | $960.8M | +0.2% |
| Inventory | $536.9M | +0.0% |
| Current Assets | $3.67B | +48.2% |
| Total Assets | $16.91B | +6.4% |
| Current Liabilities | $1.79B | -34.3% |
| Long-term Debt | $3.65B | +12.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.35B | +3.9% |
| Capital Expenditures | $107.8M | +12.5% |
| Investing Cash Flow | -$195.4M | -90.6% |
| Financing Cash Flow | $32.3M | +102.5% |
| Free Cash Flow | $1.25B | +3.2% |
| +5.7% |
| Net Income | $865.8M | +14.6% |
| EPS (Basic) | $2.46 | +16.0% |
| EPS (Diluted) | $2.43 | +15.7% |
| Stockholders' Equity |
| $10.32B |
| +6.6% |